The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Clinical Use of the Urine Biomarker [TIMP-2] × [IGFBP7] for Acute Kidney Injury Risk Assessment
Open accessAbstract
Acute kidney injury (AKI) is a devastating complication commonly occurring in the critically ill population with devastating short- and long-term consequences. Despite standardization of the definition and staging of AKI, early recognition remains challenging given that serum creatinine (Scr) is a marker—albeit imperfect—of kidney function and not kidney injury. Furthermore, the delay in rise of Scr after loss of glomerular filtration also prevents timely detection of decreased kidney function in patients with AKI. Over the past decade, numerous clinical investigations have evaluated the utility of several biomarkers in the early diagnosis and risk stratification of AKI. In 2014, the US Food and Drug Administration (FDA) approved the marketing of a test based on the combination of the urine concentrations of tissue inhibitor of metalloproteinase 2 and insulin-like growth factor binding protein 7 ([TIMP-2]x[IGFBP7]) to determine if certain critically ill patients are at risk of developing moderate to severe AKI. The optimal role of this biomarker in diagnosis, management, and prognosis of AKI in different clinical settings requires further clarification. In this perspective, we summarize the biological actions of these two cell-cycle arrest biomarkers, and present important considerations regarding the clinical application, interpretation, and limitations of this novel test for the early detection AKI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Zuo, S., Liu, C., Wang, J., Wang, F., Xu, W., Cui, S., Yuan, L., Chen, X., Fan, W., Cui, M., et al. (2012) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-012-1153-y · Cited by 58
Cited by
Nadim, M. K., Forni, L. G., Bihorac, A., Hobson, C., Koyner, J. L., Shaw, A., Arnaoutakis, G. J., Ding, X., Engelman, D. T., Gasparovic, H., et al. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.008834 · Cited by 340
Self-citationSepsis-Associated Acute Kidney Injury
Manrique-Caballero, C. L., Del Rio-Pertuz, G., & Gomez, H. (2021) · Critical Care Clinics · doi:10.1016/j.ccc.2020.11.010 · Cited by 312
Biomarkers of Drug-Induced Kidney Toxicity
Griffin, B. R., Faubel, S., & Edelstein, C. L. (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000589 · Cited by 285
Self-citation
Metadata
- Authors
- Vijayan, A., Faubel, S., Askenazi, D. J., Cerda, J., Fissell, W. H., Heung, M., Humphreys, B. D., Koyner, J. L., Liu, K. D., Mour, G., Nolin, T. D., Bihorac, A., Faubel, S., Askenazi, D. J., Basu, R. K., Bhatt, U. Y., Bihorac, A., Cerda, J., Connor, M. J., Davidson, A. J., de Caestecker, M. P., Doi, K., Fissell, W. H., Golestaneh, L., Heung, M., Humphreys, B. D., Koyner, J. L., Liu, K. D., Mour, G. K., Singh, P., Thakar, C. V., & Vijayan, A.
- Venue
- American Journal of Kidney Diseases
- Publisher
- Elsevier BV
- Published
- 2016-07
- Volume
- 68
- Issue
- 1
- Pages
- 19-28
- ISSN
- 0272-6386 (ISSN-L)
- OpenAlex
- W2289115148
- Cited by
- 250
- References
- 1
- FWCI
- 22.75
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.